CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Phase II Study of Induction Chemotherapy with Docetaxel, Capecitabine, and Cisplatin Plus Bevacizumab for Initially Unresectable Gastric Cancer with Invasion of Adjacent Organs or Paraaortic Lymph Node Metastasis
Jwa Hoon Kim, Sook Ryun Park, Min-Hee Ryu, Baek-Yeol Ryoo, Kyu-pyo Kim, Beom Su Kim, Moon-Won Yoo, Jeong Hwan Yook, Byung Sik Kim, Jihun Kim, Sun-Ju Byeon, Yoon-Koo Kang
Cancer Research and Treatment. 2018;50(2):518-529.   Published online 2017 May 24    DOI: https://doi.org/10.4143/crt.2017.005

Excel Download

2307 Phase II study of neoadjuvant chemotherapy with docetaxel, capecitabine, cisplatin and bevacizumab for initially unresectable gastric cancer with invasion of adjacent organs or paraaortic lymph node metastasis
European Journal of Cancer. 2015;51:S434   Crossref logo
Link1 Link2

Phase II Study of Induction Chemotherapy with Docetaxel, Capecitabine, and Cisplatin Plus Bevacizumab for Initially Unresectable Gastric Cancer with Invasion of Adjacent Organs or Paraaortic Lymph Node Metastasis
Cancer Research and Treatment. 2018;50(2):518-529   Crossref logo
Link1 Link2 Link3

A Multicenter Randomized Phase II Study of Docetaxel vs. Docetaxel Plus Cisplatin vs. Docetaxel Plus S-1 as Second-Line Chemotherapy in Metastatic Gastric Cancer Patients Who Had Progressed after Cisplatin Plus Either S-1 or Capecitabine
Cancer Research and Treatment. 2017;49(3):706-716   Crossref logo
Link1 Link2 Link3

2300 A multicenter randomized phase II study of docetaxel vs. docetaxel plus cisplatin vs. docetaxel plus S-1 as second-line chemotherapy in metastatic gastric cancer patients who had progressed after cisplatin plus either S-1 or capecitabine
European Journal of Cancer. 2015;51:S432   Crossref logo
Link1 Link2

A phase II study of preoperative chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy with D2 plus para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis: JCOG1002
Gastric Cancer. 2016;20(2):322-331   Crossref logo
Link1 Link2 Link3 Link4

Vorinostat in combination with capecitabine plus cisplatin as a first-line chemotherapy for patients with metastatic or unresectable gastric cancer: phase II study and biomarker analysis
British Journal of Cancer. 2016;114(11):1185-1190   Crossref logo
Link1 Link2 Link3

P-601 A phase II randomized study of thoracic radiotherapy with or without weekly docetaxel following docetaxel-cisplatin induction chemotherapy in unresectable stage IIIA-IIIB non-small cell lung cancer
Lung Cancer. 2003;41:S243   Crossref logo
Link1 Link2

Cis-diamminedichloroplatinum II based combination chemotherapy for the control of extensive paraaortic lymph node metastasis in cervical cancer
Gynecologic Oncology. 1987;26(1):71-76   Crossref logo
Link1 Link2

Docetaxel plus cisplatin as neoadjuvant chemotherapy for unresectable stage III Non-Small-Cell Lung Cancer (NSCLC): A phase II study
Lung Cancer. 2000;29(1):113   Crossref logo
Link1 Link2

6543 A phase II study of adjuvant chemotherapy with docetaxel, capecitabine and cisplatin in patients with curatively resected stage IIIb and IV advanced gastric cancer
European Journal of Cancer Supplements. 2009;7(2):374   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.